Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19
Asia Cervical Cancer Test (Screening) Market will reach US$ 4.5 Billion by 2027. Cervical cancer is a type of cancer caused due to the rampant proliferation of the cell. In 2021, as per our Report Statistics, more than 100 Million populations were diagnosed with cervical cancer. In women, cervical cancer ranks as the 4th most frequent cancer in Asia-Pacific. This increasing prevalence of cervical cancer has increased the need for cervical cancer screening tests among women. Thus, cervical cancer screening detects precancerous or cancerous changes in the cervix. It has been advised that women over 30 years of age should undergo regular Pap tests, although this may vary based on risk factors and clinical practices. The goal of screening is to find precancerous changes in the cervix so that they can be treated before shifting into full-blown cancer. This early detection may stop women from dying from cervical cancer.
Factors Driving Asia Cervical Cancer Screening Industry
The fastest-growing cervical cancer screening tests in the Asia-Pacific market attribute its development to the rising prevalence of cervical cancer in developing Asian countries like Indonesia, China, India, Malaysia, Japan, Singapore, South Korea, and Thailand. Further, the growing women population, the ever-increasing sum of structured cervical cancer programs introduced by governments and international NGOs, and the inception of low-cost cervical cancer tests are significant growth drivers for the growth of the Asia cervical cancer screening market in developing countries. According to the research Report, the Asia Cervical Cancer Test (Screening) Industry is expected to expand at a CAGR Of 3.79% during 2021-2027.
Asia Cervical Cancer Test (Screening) Market Size was US$ 3.6 Billion in 2021:
Based on type, Asia Cervical Cancer Test (Screening) market includes Pap Smear Market, HPV DNA Market, and VIA Market. Despite the declining women population, Japan has one of the significant market share in the Pap smear test market. The Pap smear test is the most useful tool for diagnosing HPV in Japanese hospitals and clinics, was the most revenue-generating segment. The Pap smear is a diagnostic procedure that helps Japanese doctors check for cervical cancer in women. It’s utilized to screen for precancerous cells on the cervix before they turn into full-blown cancer. Japanese doctors use these screening tests to find and treat irregular changes while there are still no signs of physical damage or disease – this can result in lower rates of death from cervical cancer later down the line.
Likewise, China dominates visual inspection with acetic acid (VIA) testing population. VIA (Visual Optical Inspection Using Acetic Acid) is a screening test that allows for the early detection of cervical cancer and precancerous lesions. This technique uses acetic acid, an active agent that turns the surface of the cervix white if abnormal cells or precancerous lesions are present on it. A woman places vinegar in her vagina and then has to lie down with her hips elevated to avoid losing any liquid inside.
COVID-19 Impact on Asia Cervical Cancer Test (Screening) Market:
In the COVID-19 pandemic, the number of screening tests was reduced to very low in Asia-Pacific. Lockdown has resulted in the devotion of a large number of non-urgent appointments. Things have started to move in the earlier two quarters, but the cancelation screening test numbers have not recovered to pre-COVID-19. During the attempts to deliver cervical cancer screening, preventive measures should be implemented as instructed by the health officers.
The report titled “Asia Cervical Cancer Test (Screening) Market by Type (Pap smear Market, HPV DNA Market, VIA (visual inspection with acetic acid) Market), by Countries (Indonesia, China, India, Malaysia, Japan, Singapore, South Korea, and Thailand)” provide complete detail on Asia Cervical Cancer Test (Screening) Industry.
Type - Market has been covered from 3 viewpoints:
1. Pap smear Market
2. HPV DNA Market
3. VIA (visual inspection with acetic acid) Market
Countries - Market have been covered from 8 viewpoints:
2. South Korea